NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Prepare rigorously for the NAPLEX, the pivotal examination for pharmacy licensure! Gain confidence with expertly crafted quizzes and study materials tailored for aspiring pharmacists. Elevate your understanding and skills today!

Practice this question and more.


What is a major contraindication for the use of RANKL Inhibitor: Denosumab?

  1. Hypertension

  2. Hypocalcemia

  3. Diabetes

  4. Renal impairment

The correct answer is: Hypocalcemia

A major contraindication for the use of RANKL inhibitor Denosumab is hypocalcemia. This is because Denosumab can decrease calcium levels in the blood, which can lead to serious complications such as hypocalcemia. Therefore, patients with a history of hypocalcemia should not take this medication. The other options, hypertension, diabetes and renal impairment, are not major contraindications for the use of RANKL inhibitor: Denosumab. While these conditions may require caution and monitoring, they do not completely prevent the use of the medication. It is important to consult with a healthcare provider before taking any medication and to discuss any pre-existing conditions that may affect its use.